DCGI nod to Serum Institute of India for phase 2 & 3 clinical trials of Oxford Covid-19 vaccine

Credit: IndiaTimes- Published on August 3, 2020
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford University's Covid-19 vaccine candidate in the country, according to the Health Ministry.

Video credit: ANI
Published on August 3, 2020 -  01:38
COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again
The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health Organization (WHO), a number of vaccines are now in phase-3 clinical trials. Meanwhile, Chief Minister of Madhya Pradesh Shivraj Singh Chouhan on August 03 again tested positive for COVID-19 on the 10th day of his admission to hospital. Today, Andhra Pradesh reported 7,822 new COVID-19 cases, taking the total number of coronavirus cases in the state 1,66,586. Uttar Pradesh reported 4,473 new COVID-19 cases and 50 deaths in the last 24 hours, taking active cases to 40,191 and death toll to 1,778. Tamil Nadu reported 5,609 new COVID-19 cases and 109 deaths in the last 24 hours, taking total cases to 2,63,222 including 2,02,283 discharges and 4,241 deaths.

You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions

The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to resume its phase two and three clinical trials for the..
Credit: DNA - Published 1 week ago

Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19..
Credit: IndiaTimes - Published 1 week ago


Serum Institute of India

Indian biotechnological company, vaccine manufacturer
The phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at..
Credit: IndiaTimes - Published 3 days ago



Ministry of Health and Family Welfare

Cabinet ministry of Government of India
India has reported the highest rate of Covid-19 recoveries in the world, which has crossed 80 per cent-mark, said Union Health Ministry here on Tuesday.
Credit: IndiaTimes - Published 2 days ago

"India occupies the top position in the world in terms of total recoveries. More than 43 lakhs have recovered. India's recoveries constitute 19% of total global..
Credit: IndiaTimes - Published 3 days ago

India's COVID-19 case tally crossed 54-lakh mark with a spike of 92,605 new cases and 1,133 deaths in the last 24 hours, according to the Union Ministry of..
Credit: DNA - Published 4 days ago

India has scaled yet another peak as for the first time, more than 12 lakh COVID-19 tests were conducted in the last 24 hours.
Credit: DNA - Published 4 days ago



Related videos from verified sources

UK will deliberately infect vaccine volunteers: report 01:22
Credit: Reuters Studio - Published 2 hours ago 


Watch: Farmer groups hold โ€˜rail rokoโ€™ in Punjab; BJP & Congress trade charges 04:12
Credit: HT Digital Content - Published 3 hours ago 


Johnson & Johnson's COVID-19 Vaccine Enters Phase 3 US Trials 01:22
Credit: Cover Video STUDIO - Published 3 hours ago 


Related news from verified sources

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford...
on August 3, 2020 • IndiaTimes

Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after...
on August 3, 2020 • IndiaTimes

Indiaโ€™s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage โ€” Phase 2 and 3 โ€” human trials in India for the Oxford...
on August 3, 2020 • IndiaTimes

You might like